Study Looks at Benefits of Amyloid PET in “Unclear Dementia”

Research project aims to contribute to good medical care in Germany

Heads, AI, MRI

Insights into the brain by means of artificial intelligence and “rapid” measurement methods

Smartphone-Assisted “Scavenger Hunt” Identifies People at Risk for Dementia

Study: Cognitive health status can be inferred from mobile wayfinding data.

Blood Testing for so-called MicroRNAs Can Detect Dementia

German-American research team highlights new diagnostic option for Alzheimer’s.

“Prelude” to Neuromuscular Disease SMA May Offer Chances for Better Treatment

SMA appears to be preceded by abnormalities in embryonic development that have not yet been recognized and could hold approaches for therapy.

Highly Cited

Several DZNE Scientists Among the World’s Most Impactful Researchers.

European Medicines Agency recommends approval of novel Alzheimer's drug

Susanne Wegmann, PhD, is one of the “100 Minds of Science” in Berlin

The science editors of the Berlin “Tagesspiegel” have made their choice.

Five young DZNE researchers honored with “Best Paper Award”

For the fourth time, the Breuer Foundation will award a special prize for outstanding publications by DZNE junior researchers on the topic of dementia.

Future Medicine

“Helmholtz Health Summit” convenes cutting-edge research in Berlin.

French Foundation Honors Alzheimer‘s Researcher Christian Haass

Grand Prix Européen 2024.

Around 1.5 Million Euros for Researching the Effects of “Forever Chemicals” on the Immune System

ERC awards a “Starting Grant” to Bonn researcher.

Secretary of State Pirscher visits DZNE

Among other things, she visited the clinical study unit and the PRECISE laboratories.

Swarm Learning presented at HPE Discover 2024

HPE President & CEO Antonio Neri talks about joint concept by HPE and DZNE.

"The decision is incomprehensible": Statements of DZNE experts on the refusal of "Lecanemab" by European Medicines Agency